Gennova To Finish Phase 2 & 3 Trials Of Its MRNA Jab By January 2022
[email protected]17 Dec, 2021News
Gennova Biopharmaceuticals, subsidiary of Pune-based drugmaker Emcure which is developing mRNA Covid vaccine said it plans to finish the Phase 2/3 trials by January end next year and will seek emergency use authorisation from Indian drug regulatory. Gennova has commenced Phase-2 and Phase-3 clinical trials of its mRNA based vaccine HGCO19 across 35 centres pan India.
Related Bookmarks
- Order Online Fendi Micro Peekaboo Bags
- Reinsurance Software Solutions
- Important Tips for Hiring Professional Movers
- Skin Cancer Symptoms & Treatment by Safe Health & Med Spa
- Accountants for Solicitors and Professional Practices
- Tips For Taking Care Of Tyres
- How CNC Turning Part Can Help Manufacturing Business
- Hiring the Expert Furniture Movers in Calgary For Safe Relocation
- Handrail Ball | Decoration ball half inch steel balls
- Top Benefits of Using Traditional or Modern Abstract Rugs
Recent Profiles
Volkmann Constructions
All Around Worker Llc
Trendy Layer
Poe Henderson
Batchelor Valentine
Wrenn Joyner
Ortega Mohammad
Anderson Koefoed
Sahin Fink
Purcell Williamson